Pediatric Brain Tumor Consortium (U01)

The summary for the Pediatric Brain Tumor Consortium (U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Pediatric Brain Tumor Consortium (U01): Purpose. The purpose of this open competition Funding Opportunity Announcement (FOA) is to stimulate the translation of innovative therapies suitable for children with brain tumors from the laboratory to early phase clinical testing. To achieve this goal, the National Cancer Institute (NCI) intends to continue a Pediatric Brain Tumor Consortium (PBTC) program. The NCI will support one multi-center clinical trials group (a Consortium ) that will be responsible for timely conduct of the Phase 1, Phase 2, and pilot studies evaluating novel treatment approaches relevant to the pediatric brain tumor population. The National Institute of Neurological Disorders and Stroke (NINDS), is co-sponsoring this initiative because of a shared interest with NCI in the treatment of pediatric brain tumors. NINDS will be involved in coordinating PBTC activities across other NIH-supported normal and disease-oriented brain imaging Networks (including the NCI-supported adult brain tumor consortium) as well as in aspects related to the neurocognitive, quality-of-life impact of certain treatments on long-term survivors of pediatric brain tumors. Each application submitted in response to this FOA must include plans for (i) the PBTC Operations and Statistics/Data Centers and (ii) up to seven member institutions. The proposed PBTC must be able to (i) conduct Phase 1, Phase 2, and pilot clinical trials of novel treatment approaches for children with brain tumors, focusing whenever appropriate on clinical trials that require the specialized abilities of the PBTC collaborating experienced neurosurgeons, neuro-oncologists, radiation oncologists and neuroimagers; and (ii) conduct and/or support laboratory studies related to PBTC clinical trials that may provide information relevant to the success or failure of therapy.
Federal Grant Title: Pediatric Brain Tumor Consortium (U01)
Federal Agency Name: National Institutes of Health
Grant Categories: Health Education
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-CA-08-026
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.399
CFDA Descriptions: Cancer Control
Current Application Deadline: No deadline provided
Original Application Deadline: Aug 15, 2008
Posted Date: Jun 06, 2008
Creation Date: Jun 06, 2008
Archive Date: Sep 15, 2008
Total Program Funding: $2,200,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Others (see text field entitled "Additional Information on Eligibility" for clarification) For profit organizations other than small businesses Public and State controlled institutions of higher education Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments Private institutions of higher education
Additional Information on Eligibility
Other Eligible Applicants include the following: Eligible Agencies of the Federal Government; Regional Organizations; U.S. Territory or Possession.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R...
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R...
HLA and KIR Region Genomics in Immune-Mediated Diseases (U01 Clinical Trial Not Allowed)
Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinar...
Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 - Clinica...
Exploratory Grants for Behavioral Research in Cancer Control
Decision Making in Cancer: Single-Event Decisions
Small Grants for Behavioral Research in Cancer Control (R03)
More Grants from the National Institutes of Health
Ethical Issues in Translational Science Research (R01 Clinical Trial Optional)
A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease...
Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not All...
HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Instit...
National Dental Practice-Based Research Network Clinical Trial or Observational Study Plan... is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2020